Improving treatment for gastric cancer in Latino patients using personalized models
Advancing gastric cancer precision medicine in Latinos through patient-derived modeling
This study is looking at gastric cancer in Latino patients to find specific genetic changes in their tumors that can be targeted with current treatments, hoping to create better and more personalized care for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10896242 on NIH RePORTER |
What this research studies
This research focuses on understanding gastric cancer, which disproportionately affects Latino populations, by creating patient-derived models that reflect the unique genetic characteristics of their tumors. The approach involves analyzing the molecular subtypes of gastric cancer in Latino patients to identify 'druggable' mutations that can be targeted with existing therapies. By studying the complex genetic alterations in these tumors, the research aims to develop more effective treatment strategies tailored specifically for Latino patients. This could lead to better outcomes and reduced disparities in gastric cancer treatment and survival.
Who could benefit from this research
Good fit: Ideal candidates for this research are Latino individuals diagnosed with gastric cancer, particularly those with specific genetic mutations.
Not a fit: Patients who do not have gastric cancer or those outside the Latino demographic may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized treatment options for Latino patients with gastric cancer.
How similar studies have performed: Previous research has shown success in using patient-derived models to identify targeted therapies for various cancers, indicating a promising approach for this study.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Carvajal Carmona, Luis Guillermo — University of California at Davis
- Study coordinator: Carvajal Carmona, Luis Guillermo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.